[
  {
    "ts": "2025-10-18T01:16:57+00:00",
    "headline": "A Look at Gilead Sciences’s Valuation Following Breakthrough HIV and Cancer Clinical Trial Results",
    "summary": "Gilead Sciences (GILD) is drawing attention this week as it presents new clinical results at both the European AIDS Conference and the European Society for Medical Oncology. Updates include HIV treatment advances and important data from cancer trials. See our latest analysis for Gilead Sciences. After unveiling positive data at major scientific conferences, Gilead Sciences is enjoying a notable run, with its share price climbing nearly 34% year-to-date and delivering an impressive 1-year...",
    "url": "https://finance.yahoo.com/news/look-gilead-sciences-valuation-following-011657859.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ee929940-62c5-3f8b-847e-4d36fcff125b",
      "content": {
        "id": "ee929940-62c5-3f8b-847e-4d36fcff125b",
        "contentType": "STORY",
        "title": "A Look at Gilead Sciences’s Valuation Following Breakthrough HIV and Cancer Clinical Trial Results",
        "description": "",
        "summary": "Gilead Sciences (GILD) is drawing attention this week as it presents new clinical results at both the European AIDS Conference and the European Society for Medical Oncology. Updates include HIV treatment advances and important data from cancer trials. See our latest analysis for Gilead Sciences. After unveiling positive data at major scientific conferences, Gilead Sciences is enjoying a notable run, with its share price climbing nearly 34% year-to-date and delivering an impressive 1-year...",
        "pubDate": "2025-10-18T01:16:57Z",
        "displayTime": "2025-10-18T01:16:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HAEiJmFsYXJTRBPxnneP6w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hXB9F2qU7k4qk3_k1DQd9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/look-gilead-sciences-valuation-following-011657859.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/look-gilead-sciences-valuation-following-011657859.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]